bpc 157 ankylosing spondylitis Ankylosing Spondylitis - Rheumatology -
Description
BPC-157 has no FDA-approved human therapeutic application, and published human pharmacokinetic data for this exact finished product and dose could not be verified in the peer-reviewed literature reviewed for this article
This product usually has no side effects
Physical Symptoms Extreme fatigue or weakness
Research on the IGF-1 signaling cascade ties this same pathway to larger muscle fibers and slower muscle breakdown
